Monogram Orthopaedics Inc. (MGRM)
NASDAQ: MGRM · IEX Real-Time Price · USD
4.96
+0.19 (3.98%)
Jun 2, 2023, 10:02 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0.63 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0.46 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0.17 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.64 | 5.17 | 2.18 | 0.84 | 0.59 | 0.57 |
| Research & Development | 4.97 | 5.28 | 4.67 | 0.19 | 0.03 | 0.05 |
| Other Operating Expenses | 0 | 0 | 0 | 0.65 | 0.03 | 0 |
| Operating Expenses | 10.61 | 10.45 | 6.85 | 1.68 | 0.65 | 0.62 |
| Operating Income | -10.61 | -10.28 | -6.85 | -1.68 | -0.65 | -0.62 |
| Interest Expense / Income | 0 | 0 | 0.05 | 0.12 | 0.06 | 0.02 |
| Other Expense / Income | 3.08 | 1.54 | 2.16 | -0 | -0 | 0.01 |
| Pretax Income | -13.69 | -11.81 | -9.07 | -1.8 | -0.71 | -0.66 |
| Net Income | -13.69 | -11.81 | -9.07 | -1.8 | -0.71 | -0.66 |
| Shares Outstanding (Basic) | 10 | 10 | 9 | 6 | 0 | 0 |
| Shares Outstanding (Diluted) | 10 | 10 | 9 | 6 | 0 | 0 |
| Shares Change | - | 5.94% | 57.65% | 2702.60% | 17.72% | - |
| EPS (Basic) | -1.42 | -1.22 | -0.99 | -0.31 | -3.44 | -3.75 |
| EPS (Diluted) | -1.42 | -1.22 | -0.99 | -0.31 | -3.44 | -3.75 |
| Free Cash Flow Per Share | -0.90 | -0.95 | -0.72 | -0.18 | -2.23 | -4.39 |
| Gross Margin | - | 26.99% | - | - | - | - |
| Operating Margin | - | -1635.93% | - | - | - | - |
| Profit Margin | - | -1880.63% | - | - | - | - |
| Free Cash Flow Margin | - | -1464.25% | - | - | - | - |
| EBITDA | -13.3 | -11.49 | -8.92 | -1.64 | -0.62 | -0.62 |
| EBITDA Margin | - | -1829.38% | - | - | - | - |
| Depreciation & Amortization | 0.39 | 0.32 | 0.1 | 0.03 | 0.03 | 0.01 |
| EBIT | -13.69 | -11.81 | -9.01 | -1.67 | -0.65 | -0.64 |
| EBIT Margin | - | -1880.63% | - | - | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).